The Skylife Phototherapy System
There is a problem in the industry today when neonates are being readmitted to the hospital or the neonate length of stay is long. 18 of 1000 newborns with gestational ages between 34 and 42 weeks who were cared for in WBNs were readmitted within their first 4 weeks of life.1
Out of the 3.7M births in the US each year, studies show that ~$800M will be spent on jaundice related re-admissions. There are no viable home-based treatments for jaundice.
The ideal solution to this problem is a phototherapy system that provides effective jaundice treatment quickly and easily in the hospital and the home, that mitigates re-admissions and frustrations of jaundice treatment, and reduces cost.
The Skylife Phototherapy System has the highest spectral power on the market which facilitates reduction in discharge time, re-admittance, and promotes family bonding through efficiency, safety, quality, and ease of use.